COVID-19 Global & China Ophthalmology Disorders Drug Market Research by Company, Type & Application 2015-2026

Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Oral
1.1.2.2 Injection
1.1.2.3 External Use
1.1.3 Market by Application
1.1.3.1 Juvenile Macular Degeneration (Stargardt Disease)
1.1.3.2 Leber Congenital Amaurosis (LCA)
1.1.3.3 Leber's Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
1.1.3.4 Usher Syndrome
1.1.3.5 Retinitis Pigmentosa (Retinitis)
1.2 Global & China Market Size & Forecast
1.2.1 Global Market (2015-2020 & 2021-2026)
1.2.2 China Market (2015-2020 & 2021-2026)
2 Global & China Market by Company
2.1 Global Sales by Company
2.2 China Sales by Company
3 Global & China Market by Type
3.1 Global Sales by Product Type
3.2 China Sales by Product Type
4 Global & China Market by Application
4.1 Global Sales by Application
4.2 China Sales by Application
5 China Trade
5.1 Export Overview
5.2 Import Overview
6 Key Companies List
6.1 Sanofi
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Bayer
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Bausch + Lomb
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Novartis
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Usher Syndrome
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Takeda Pharmaceutical
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Roche
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Pfizer
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Allergan
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Gilead Sciences
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Kubota Pharmaceutical
6.11.1 Company Information
6.11.2 Product Specifications
6.11.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 Alkeus Pharmaceuticals
6.12.1 Company Information
6.12.2 Product Specifications
6.12.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.13 Astellas Pharma
6.13.1 Company Information
6.13.2 Product Specifications
6.13.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.14 Ferrer Corporate
6.14.1 Company Information
6.14.2 Product Specifications
6.14.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.15 Amgen Inc
6.15.1 Company Information
6.15.2 Product Specifications
6.15.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.16 Editas Medicine Inc
6.16.1 Company Information
6.16.2 Product Specifications
6.16.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.17 ProQR Therapeutics NV
6.17.1 Company Information
6.17.2 Product Specifications
6.17.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.18 ReNeuron
6.18.1 Company Information
6.18.2 Product Specifications
6.18.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.19 Amarantus BioScience
6.19.1 Company Information
6.19.2 Product Specifications
6.19.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.20 Ocugen
6.20.1 Company Information
6.20.2 Product Specifications
6.20.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.21 ReGenX Biosciences
6.21.1 Company Information
6.21.2 Product Specifications
6.21.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.22 Sucampo Pharmaceuticals
6.22.1 Company Information
6.22.2 Product Specifications
6.22.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.23 Orphagen Pharmaceuticals
6.23.1 Company Information
6.23.2 Product Specifications
6.23.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.24 Okuvision
6.24.1 Company Information
6.24.2 Product Specifications
6.24.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.25 Second Sight Medical
6.25.1 Company Information
6.25.2 Product Specifications
6.25.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.26 Acucela
6.26.1 Company Information
6.26.2 Product Specifications
6.26.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.27 Stealth BioTherapeutics
6.27.1 Company Information
6.27.2 Product Specifications
6.27.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.28 Sun Pharma Advanced Research Company
6.28.1 Company Information
6.28.2 Product Specifications
6.28.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.29 AmpliPhi Biosciences
6.29.1 Company Information
6.29.2 Product Specifications
6.29.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.30 Applied Genetic Technologies
6.30.1 Company Information
6.30.2 Product Specifications
6.30.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.31 Asklepios BioPharmaceutical
6.31.1 Company Information
6.31.2 Product Specifications
6.31.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.32 Biovista
6.32.1 Company Information
6.32.2 Product Specifications
6.32.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.33 Spark Therapeutics
6.33.1 Company Information
6.33.2 Product Specifications
6.33.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.34 Caladrius Biosciences
6.34.1 Company Information
6.34.2 Product Specifications
6.34.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.35 Dompe Farmaceutici
6.35.1 Company Information
6.35.2 Product Specifications
6.35.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.36 Dormant Projects
6.36.1 Company Information
6.36.2 Product Specifications
6.36.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.37 Grupo Ferrer Internacional
6.37.1 Company Information
6.37.2 Product Specifications
6.37.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.38 ID Pharma
6.38.1 Company Information
6.38.2 Product Specifications
6.38.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.39 InFlectis BioScience
6.39.1 Company Information
6.39.2 Product Specifications
6.39.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.40 Ionis Pharmaceuticals
6.40.1 Company Information
6.40.2 Product Specifications
6.40.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.41 Ixchel Pharma
6.41.1 Company Information
6.41.2 Product Specifications
6.41.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.42 Khondrion
6.42.1 Company Information
6.42.2 Product Specifications
6.42.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.43 Mimetogen Pharmaceuticals
6.43.1 Company Information
6.43.2 Product Specifications
6.43.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.44 Mitotech
6.44.1 Company Information
6.44.2 Product Specifications
6.44.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.45 M's Science
6.45.1 Company Information
6.45.2 Product Specifications
6.45.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.46 Nanovector
6.46.1 Company Information
6.46.2 Product Specifications
6.46.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.47 SanBio
6.47.1 Company Information
6.47.2 Product Specifications
6.47.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Upstream Overview
8 Policies & Market Environment
8.1 Policies
8.1.1 Major Regions Policies
8.1.2 Policies in China
8.2 Market Environment
8.2.1 Porter's Five Forces
8.2.2 Impact of COVID-19
9 Research Conclusion